EP0165: AN Open-Label, Multicenter, Outpatient Extension Study To Evaluate The Safety and Tolerability of Staccato Alprazolam In Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Grants and Contracts Details

StatusActive
Effective start/end date8/2/238/2/25

Funding

  • UCB Pharma (domestic): $6,431.00